CIMB:MYXCIMB Group Holdings Bhd Analysis
Data as of 2026-03-11 - not real-time
IDR 1,755.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
PT Bank CIMB Niaga trades at a **low P/E ratio** far below the industry average and a **price‑to‑book well under one**, signaling a clear valuation discount. The stock also offers an **attractive dividend yield near 9%** with a payout ratio comfortably below 60%, suggesting the dividend is sustainable.
The technical picture shows a **bullish trend** as the price sits above the 20‑day and 50‑day SMAs, while the 30‑day volatility is elevated, indicating ample room for price movement. The RSI is in oversold territory and the MACD shows a bearish divergence, but the price is above the key support level and volume is on an upward trajectory, hinting at short‑term upside potential.
Risk‑wise, the beta is near zero, giving the stock a **defensive market profile**, yet the 30‑day volatility and negative operating cash flow introduce medium‑level concerns. Sector‑specific regulatory exposure and Indonesia’s emerging‑market dynamics add moderate geographic and regulatory risk, but the combination of **value pricing, strong dividend income, and low market sensitivity** supports a positive outlook across horizons.
The technical picture shows a **bullish trend** as the price sits above the 20‑day and 50‑day SMAs, while the 30‑day volatility is elevated, indicating ample room for price movement. The RSI is in oversold territory and the MACD shows a bearish divergence, but the price is above the key support level and volume is on an upward trajectory, hinting at short‑term upside potential.
Risk‑wise, the beta is near zero, giving the stock a **defensive market profile**, yet the 30‑day volatility and negative operating cash flow introduce medium‑level concerns. Sector‑specific regulatory exposure and Indonesia’s emerging‑market dynamics add moderate geographic and regulatory risk, but the combination of **value pricing, strong dividend income, and low market sensitivity** supports a positive outlook across horizons.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- RSI indicates oversold conditions with near‑term upside
- Price is comfortably above short‑term support
- Rising volume supports momentum
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Significant valuation discount relative to peers
- High dividend yield provides income cushion
- Negative operating cash flow warrants caution
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Sustained dividend income at attractive yield
- Low beta offers defensive characteristics
- Valuation gap versus industry suggests long‑run upside
Key Metrics & Analysis
Financial Health
Revenue Growth6.30%
Profit Margin38.72%
P/E Ratio6.4
ROE12.46%
ROA1.89%
P/B Ratio0.8
Op. Cash FlowIDR-6691461005312
Industry P/E17.3
Technical Analysis
TrendBullish
RSI34.2
SupportIDR 1,720.00
ResistanceIDR 1,905.00
MA 20IDR 1,833.50
MA 50IDR 1,823.70
MA 200IDR 1,749.43
MACDBearish
VolumeIncreasing
Fear & Greed Index76.91
Valuation
Target PriceIDR 2,166.00
Upside/Downside23.42%
GradeUndervalued
TypeValue
Dividend Yield8.95%
Risk Assessment
Beta0.08
Volatility21.07%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.